Gene · 8915
Papers2,643
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,643
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The absence of early malignant changes in women subjected to Aquafilling breast augmentation on the basis of E-cadherin and N-cadherin immunohistochemical expression. | Cent Eur J Immunol | 2022 | 36817402 | PubTator, text mining | PubMed |
| Skin manifestations of inborn errors of NF-κB. | Front Pediatr | 2022 | 36733767 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of miRNAs Targeting TRAF5 in DLBCL Involving in NF-κB Signaling Pathway and Affecting the Apoptosis and Signal Transduction. | Genet Res (Camb) | 2022 | 36619898 | PubTator, text mining | PubMed |
| Insights into mucosal associated invariant T cell biology from human inborn errors of immunity. | Front Immunol | 2022 | 36618406 | PubTator, text mining | PubMed |
| CARMA3: A potential therapeutic target in non-cancer diseases. | Front Immunol | 2022 | 36618379 | PubTator, text mining | PubMed |
| Diagnosis and Treatment for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma. | J Clin Med | 2022 | 36614921 | PubTator, text mining | PubMed |
| Initial characterization of immune microenvironment in pheochromocytoma and paraganglioma. | Front Genet | 2022 | 36568391 | PubTator, text mining | PubMed |
| Cutaneous and Developmental Effects of CARD14 Overexpression in Zebrafish. | Biomedicines | 2022 | 36551948 | PubTator, text mining | PubMed |
| Solid pancreatic masses in children: A review of current evidence and clinical challenges. | Front Pediatr | 2022 | 36507125 | PubTator, text mining | PubMed |
| Development and validation of a chromatin regulator prognostic signature in colon adenocarcinoma. | Front Genet | 2022 | 36506326 | PubTator, text mining | PubMed |
| Yamogenin-Induced Cell Cycle Arrest, Oxidative Stress, and Apoptosis in Human Ovarian Cancer Cell Line. | Molecules | 2022 | 36500274 | PubTator, text mining | PubMed |
| Joining Forces for Cancer Treatment: From "TCR versus CAR" to "TCR and CAR". | Int J Mol Sci | 2022 | 36498890 | PubTator, text mining | PubMed |
| HeLa Cervical Cancer Cells Are Maintained by Nephronophthisis 3-Associated Primary Cilium Formation via ROS-Induced ERK and HIF-1α Activation under Serum-Deprived Normoxic Condition. | Int J Mol Sci | 2022 | 36498831 | PubTator, text mining | PubMed |
| The Autologous Hematopoietic Stem Cells Transplantation Combination-Based Chimeric Antigen Receptor T-Cell Therapy Improves Outcomes of Relapsed/Refractory Central Nervous System B-Cell Lymphoma. | J Oncol | 2022 | 36483984 | PubTator, text mining | PubMed |
| Fungal sensing by dectin-1 directs the non-pathogenic polarization of TH17 cells through balanced type I IFN responses in human DCs. | Nat Immunol | 2022 | 36456734 | PubTator, text mining | PubMed |
| CARD11 mutation and HBZ expression induce lymphoproliferative disease and adult T-cell leukemia/lymphoma. | Commun Biol | 2022 | 36446869 | PubTator, text mining | PubMed |
| CARD9 in host immunity to fungal, bacterial, viral, and parasitic infections: An update. | Front Microbiol | 2022 | 36439825 | PubTator, text mining | PubMed |
| Investigation of key signaling pathways and appropriate diagnostic biomarkers selection between non-invasive to invasive stages in pancreatic cancer: a computational observation. | J Med Life | 2022 | 36415513 | PubTator, text mining | PubMed |
| Expanding spectrum, intrafamilial diversity, and therapeutic challenges from 15 patients with heterozygous CARD11-associated diseases: A single center experience. | Front Immunol | 2022 | 36405754 | PubTator, text mining | PubMed |
| Inflammatory monocyte gene signature predicts beneficial within group effect of simvastatin in patients with schizophrenia spectrum disorders in a secondary analysis of a randomized controlled trial. | Brain Behav Immun Health | 2022 | 36405425 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8915/papers?page=17